Skip to content

Flash Glucose Measurement in Patients on Total Parenteral Nutrition

What Happens to Frequently Measured Glucose Measures in Patients, Both With and Without Diabetes, Who Are Receiving Total Parenteral Nutrition (TPN).

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03871660
Enrollment
10
Registered
2019-03-12
Start date
2019-03-01
Completion date
2019-10-31
Last updated
2019-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Total Parenteral Nutrition

Brief summary

IV nutrition is a means of providing all the nutritional requirements of people who have severe bowel disease. At least 10% of people on longer term IV nutrition also have diabetes and IV nutrition includes delivering glucose directly to large veins. Unsurprisingly this causes elevated blood glucose levels, particularly in people with diabetes. This can make treatment of hyperglycaemia more challenging. As a result this study aims to use a flash glucose monitoring device, the FreeStyle Libre pro, to investigate what happens to glucose levels in patients receiving IV nutrition. We will look at this trend in 5 patients with diabetes and 5 patients without diabetes receiving IV nutrition.

Interventions

Flash glucose monitoring device. Measures patients interstitial glucose levels continuously.

Sponsors

The Leeds Teaching Hospitals NHS Trust
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants receiving TPN in Leeds with or without diabetes

Exclusion criteria

* Patients not receiving TPN * Patients who do not speak English * Patients who are unable to give consent

Design outcomes

Primary

MeasureTime frameDescription
Hyperglycaemia14 daysMeasurements of hyperglycaemia through interstitial glucose levels in patients on a TPN regime

Countries

United Kingdom

Contacts

Primary ContactMichael W Mansfield, BM BCh, BA (hons)
michael.mansfield@nhs.net01132066963

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026